Deals > All

East Germany North Germany South Germany West Germany Austria Germany Switzerland [ # 12 & 35 ]

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
1 2 3 ... 36 37 38 ... 54 55 56

Deal: Collaboration or Financing	Date
Haplogen–Evotec: virostatic agents, 201211– collab €na discovery + developm of small molecules against viral infections	2012-11-15
Tecan–Promega: lab automation equipment, 201212 collab product integration Freedom EVO – HSM workstation incl ReliaPrep gDNA Isolation System	2012-11-15
Alacris–MC Services: public relations, 201211 service existent for Alacris Theranostics GmbH	2012-11-14
GSK–Alacris: ModCell system, 201211– supply service using ModCell cancer model for drug stratification in early cancer drug discovery	2012-11-14
RJ Lee Group–Ionicon: mass spectrometer, 201211 supply existent use of PTR-MS instrument in mobile lab by RJ Lee	2012-11-13
Univ Tübingen–Germany (govt): grant, 201211– GO-Bio grant €1.7m for 2.5y for NMI project »Biomarker Tests for Drug Developom« from BMBF	2012-11-13
GeneQuine–Hamburg (govt): investment, 201211 seed financing round totalling €1m incl €500k from Innovationsstarter Hamburg	2012-11-12
GeneQuine–High-Tech Gründerfonds: investment, 201211 seed financing round totalling €1m incl €500k from HTGF	2012-11-12
GeneQuine–SEVERAL: investment, 201211 seed financing round €1m from Innovationsstarter Hamburg + HTGF	2012-11-12
Bruker Corp–Thermo Fisher: UltiMate LC system, 201211 collab co-marketing of UltiMate 3000 Standard LC with amaZon SL system by Bruker	2012-11-09
4SC–MC Services: public relations, 201211 service existent for 4SC AG	2012-11-08
Cysal–eCapital: investment, 201211 seed financing round totalling €1m incl €500k from Gründerfonds Münsterland	2012-11-08
Cysal–High-Tech Gründerfonds: investment, 201211 seed financing round totalling €1m incl €500k from HTGF II	2012-11-08
Cysal–SEVERAL: investment, 201211 seed financing round €1m from Gründerfonds Münsterland + HTGF II	2012-11-08
Lophius–Germany (govt): grant, 201211 ZIM solo grant €140k from BMWi	2012-11-08
CeGaT–Genomatix Software: molecular diagnostics, 201211 collab existent DNA sequence analysis for diagnostics	2012-11-07
Novartis–MorphoSys: HuCAL technology, 201211– collab expansion strategic alliance €na to include newly launched Ylanthia platform	2012-11-07
CCS Cell Culture Service–Cevec: CAP-T technology, 201211– license to offer CAP-T cells for cell -based assays + protein production	2012-11-05
Cypher Genomics–Biobase: genomic software tools, 201211– supply Genome Trax Knowledgebase to be used by Cypher for sequencing variant analysis	2012-11-05
Zeltia–Scienion: DNA microarrays, 201211– collab expansion product integration to provide molecular microarray solutions Genomia SAU	2012-11-05
Bruker Corp–Horiba: SPRi-MALDI platform, 201211– product integration + co-marketing of integrated SPRi-MALDI-MS system	2012-11-01
Univ Maryland–Thermo Fisher: mass spectrometer, 201211c supply Thermo LTQ Orbitrap Velos MS w ETD + NanoLC system to MS Facility at School of Pharmacy	2012-11-01
Phenex–SEVERAL: investment, 201210 financing round Series D €5m from existing investors incl EVP/RVP	2012-10-31
3D-MASSOMICS project–EU (govt): grant, 201210– FP7 grant €2.8m	2012-10-30
Tecan–Automation Partnership: automated cell culture system, 201210– collab co-promotion Freedom EVO with TAP Biosstems’ RAFT 3D cell culture system	2012-10-30
Crossing Automation–Brooks Automation: investment, 201210 acquisition $69m subject to working capital adjustment at closing	2012-10-29
EADS–Ionicon: mass spectrometer, 201210 supply existent PTR-TOF 8000 MS for several A330/A340 Airbus aircraft for air testing	2012-10-29
Menarini–Oxford BioTherapeutics: antibody cancer drug, 201210– strategic alliance to develop 5 of OBT’s AB + ADC programs	2012-10-29
Bayer–Qiagen: molecular companion diagnostics, 201210– collab developm tests for cancer drug candidates by Qiagen Manchester	2012-10-25
Cevec–SEVERAL: investment, 201210 financing round Series C €2.8m from Charité Biomedical Fund + Midas + Creathor Venture + NRW.Bank	2012-10-24
4SC–Germany (govt): grant, 201210– research grant €600k for developm personalised cancer drugs within m4 Cluster	2012-10-23
OncoMed Pharmaceuticals–Lonza: MAb contract manufacturing, 201210– supply process developm + manufacturing + GS license for MAb cancer drugs	2012-10-23
Sentinel Services (ZA)–SGS: investment, 201210 acquisition of Sentinel Services (Pty) Ltd by SGS SA	2012-10-22
Thermo Fisher–Univ Utrecht: mass spectrometry, –201210 collab advancement of Orbitrap mass analyzer using Exactive Plus MS by AJR Heck + A Makarov	2012-10-22
Protea Biosciences–Thermo Fisher: mass spectrometer, 201210 supply existent LTQ Velos MS at newly opended MSIC	2012-10-20
Dichrom–Protea Biosciences: mass spectrometry services, 201210– supply of MS services of new ProteaBio MS Center in German-speaking Europe by Dichrom	2012-10-19
Metrohm–Analytik Jena: ion chromatography, 201210 collab developm + supply new Combustion Module by Analytik Jena for Methrom’s CIC system	2012-10-19
Auxogyn–Merck (DE): prenatal diagnostics, 201210– collab Merck Serono to support development + commercialisation of Eeva Test	2012-10-18
Mitsubishi Chemical–Covagen: FynomAb technology, 201210– collab + license €4m upfront + €108.25m milestones + royalties per target pair with TRL	2012-10-17
Nextval–Bruker Corp: mass spectrometer, 201210– collab using ultrafleXtreme system + Compass s/w with Nextval’s MassInsight technology	2012-10-16
Thermo Fisher–Immundiagnostik: MS-based proteomic assays, 201210– collab developm product integration ImmunoTube technology with LC-MS/MS	2012-10-16
Merck (US)–Strüngmann Group: virostatic agents, 201210– license excl ww HCMV portfolio incl letermovir €110m upfront + €332.5m + royalties fr AiCuris	2012-10-15
Addex–SEVERAL: investment, 201210 private placement $10.3m gross proceeds 918k new ordinary shares CHF10.5/share to institutional investors	2012-10-12
JeNaCell–High-Tech Gründerfonds: investment, 201210 seed financing totalling €700k from HTGF + STIFT	2012-10-12
JeNaCell–SEVERAL: investment, 201210 seed financing €700k from HTGF + STIFT	2012-10-12
JeNaCell–Thuringia (govt): investment, 201210 seed financing totalling €700k from HTGF + STIFT	2012-10-12
Analytik Jena–Russian Academy of Sciences: analytical instruments, 201210 collab new Analytik Jena Competence Center located at Zelinsky Institute	2012-10-09
InterLab (RU)–Analytik Jena: analytical instruments, 201210 existent most imporant sales partner in Russia + partner for Competence Center in Moscow	2012-10-09
November–R-Biopharm: investment, 201210 acquisition €na 100% of Progen Biotechnik GmbH out of bankrupt November AG i IN	2012-10-09
Affimed–Aeris Capital: investment, 201210 financing round Series D totalling €15.5m incl investor Aeris Capital	2012-10-08
Affimed–BioMedPartners: investment, 201210 financing round Series D totalling €15.5m incl investor BioMedInvest	2012-10-08
Affimed–Life Sciences Partners: investment, 201210 financing round Series D totalling €15.5m incl investor LSP	2012-10-08
Affimed–Novo Group: investment, 201210 financing round Series D totalling €15.5m incl investor Novo Nordisk A/S	2012-10-08
Affimed–OrbiMed: investment, 201210 financing round Series D totalling €15.5m incl investor Orbimed	2012-10-08
Affimed–SEVERAL: investment, 201210 financing round Series D €15.5m	2012-10-08
COSMOS project–EU (Govt): grant, 201210– FP7 funding €2m for COordination Of Standards in MetabOlomicS	2012-10-08
Creathor Venture–SEVERAL: investment, 201210 final closing €80m Creathor Venture Fund III incl investor EIF	2012-10-05
Sweden (govt)–Bruker Corp: mass spectrometer, 201210 supply existent maXis impact incl use of new PesticideScreener solution at NFA	2012-10-05
Tecan–BioNTech: peptide microarray technology, 201210– collab co-promotion JPT peptide arrays with Tecan microarray handling devices	2012-10-02
AMP-Therapeutics–Germany (govt): grant, 201210–201409 BMBF Innovative Therapies grant totalling €1.8m to AMP + Univ Leipzig	2012-10-01
Bayer–Evotec: drug discovery services, 201210– collab 5y €12m upfront + up to €580m milestones developm of 3 drug candidates to treat endometriosis	2012-10-01
Definiens–Cipio Partners: investment, 201210 private financing round totalling €10m incl returning co-investor Cipio	2012-10-01
Definiens–Gilde Investment: investment, 201210 private financing round totalling €10m incl new + lead investor Gilde Healthcare Partners	2012-10-01
Definiens–SEVERAL: investment, 201210 private financing round €10m led by new investor Gilde Healthcare Partners	2012-10-01
Definiens–TVM: investment, 201210 private financing round totalling €10m incl returning co-investor TVM	2012-10-01
GeneWake–Germany (govt): grant, 201210– 3-year BMBF grant €450k to develop pharmacodiagnostic test for colon cancer	2012-10-01
Piqur Therapeutics–SEVERAL: investment, 201210 seed funding from private investors + KTI	2012-10-01
STATegra project–EU (govt): grant, 201210–201509 FP7 funding €6m out of total project cost of €7.85m	2012-10-01
Leco–Genedata: mass spectrometry software, 201209 collab existent product integration Expressionist MSX s/w with High Resolution TOFMS	2012-09-25
Ayoxxa–High-Tech Gründerfonds: investment, 201209 financing round Series A totalling €2.6m incl co-investor HTGF	2012-09-20
Ayoxxa–North Rhine-Westphalia (govt): investment, 201209 financing round Series A totalling €2.6m incl co-investor NRW.BANK	2012-09-20
Ayoxxa–PERSON: investment, 201209 financing round Series A totalling €2.6m incl co-investor Gregor Siebenkotten	2012-09-20
Ayoxxa–PERSON: investment, 201209 financing round Series A totalling €2.6m incl co-investor Rainer Christine	2012-09-20
Ayoxxa–SEVERAL: investment, 201209 financing round Series A €2.6m led by Wellington Partners	2012-09-20
Ayoxxa–Wellington Partners: investment, 201209 financing round Series A totalling €2.6m incl lead investor Wellington Partners	2012-09-20
Genalyte–Scienion: print/spotting technology, 201209– co-marketing of sciFlexarrayer S5 + offering of custom spotting services by Genalyte	2012-09-19
Pasteuria Bioscience–Syngenta: investment, 201209 acquisition $86m + $27m milestones ANNOUNCED	2012-09-19
CureVac–Hopp Group: investment, 201209 financing round Series D €80m from dievini Hopp BioTech Holding	2012-09-18
IRIS International–Danaher: investment, 201209–201210 acquisition $338m cash tender offer $19.5/share to be integrated in Beckman Coulter Dx business	2012-09-17
Bruker Corp–Russian Academy of Sciences: ParaCell technology, 201209 collab existent integration of ParaCell in new solariX XR FTMS system	2012-09-16
Teva–Bayer: investment, 201209–201301 acquisition $60m upfront + $85m milestones of US animal health business of Teva by Bayer HealthCare	2012-09-14
Lepu Medical–Qiagen: ESEQuant Lateral Flow System, 201209– supply OEM marketed as LEPU Quant-Gold w cardiac markers in China by Lepu	2012-09-13
Bruker Corp–Univ Washington: Skyline software, 201207 collab integration of Skyline s/w with maXis mass spectrometers MacCoss Lab of Biological MS	2012-09-10
Scienion–Maine Manufacturing: protein microarray technology, 201209– non-excl ww distribution of FAST Slide product line by Scienion	2012-09-10
Thermo Fisher–Protein Metrics: proteomic s/w tools, 201207– license Byonic database search s/w for integration w Proteome Discoverer + Preview s/w	2012-09-10
Boehringer–ETH Zürich: diabetes + obesity research, 201209– collab translational research Institutes of Mol Health Science + Food Nutrition Health	2012-09-06
Sigma-Aldrich–Danaher: mass spectrometry reagents, 201209– distribution ww of iChemistry Solutions of AB Sciex	2012-09-06
F2G Ltd–SEVERAL: investment, 201209 financing round $30m incl new investors Advent Life Sciences + Novartis Bioventures	2012-09-05
High-Tech Gründerfonds–SAP: investment, 201209 investment in High-Tech Gründerfonds II by SAP Ventures	2012-09-04
Merck (DE)–Quartz Bio: bioinformatics, 201209– supply service approx €2m with next 2 to 3 years to Merck Serono	2012-09-03
Molegro–CLC bio: investment, 201209 acquisition €na by CLC bio A/S	2012-09-03
Deutsches Epigenom-Projekt DEEP–Germany (govt): grant, 201209–201708 BMBF grant €16m for 5 years	2012-09-01
Deutsches Epigenom-Projekt DEEP–Qiagen: epigenomics, 201209–201708 Qiagen GmbH is a project partner	2012-09-01
Merck (DE)–Symphogen: antibody cancer drug, 201209–201501 ww license to Sym004 RIGHTS RETURNED 1/15	2012-09-01
SuppreMol–SEVERAL: investment, 201209 financing round Series D 1st closing €6.5m	2012-09-01
Implandata–EnjoyVenture: investment, 201208 financing round Series A 2nd closing totalling €1.6m Peppermint + EnjoyVenture + KfW	2012-08-24
Implandata–Germany (govt): investment, 201208 financing round Series A 2nd closing totalling €1.6m Peppermint + EnjoyVenture + KfW	2012-08-24
Implandata–Peppermint: investment, 201208 financing round Series A 2nd closing totalling €1.6m Peppermint + EnjoyVenture + KfW	2012-08-24
Implandata–SEVERAL: investment, 201208 financing round Series A 2nd closing €1.6m Peppermint + EnjoyVenture + ERP Startfonds of KfW	2012-08-24
Univ Maryland–Bruker Corp: mass spectrometer, 201208 supply existent Bruker AmaZon X Ion Trap MS at MS Facility at School of Pharmacy	2012-08-24

1 2 3 ... 36 37 38 ... 54 55 56

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

Deals > All